100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
BCMAS Exam | Questions & Answers (100 %Score) Latest Updated 2024/2025 Comprehensive Questions A+ Graded Answers | With Expert Solutions $13.48   Add to cart

Exam (elaborations)

BCMAS Exam | Questions & Answers (100 %Score) Latest Updated 2024/2025 Comprehensive Questions A+ Graded Answers | With Expert Solutions

 4 views  0 purchase
  • Course
  • BCMAS
  • Institution
  • BCMAS

BCMAS Exam | Questions & Answers (100 %Score) Latest Updated 2024/2025 Comprehensive Questions A+ Graded Answers | With Expert Solutions

Preview 4 out of 33  pages

  • August 4, 2024
  • 33
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • BCMAS
  • BCMAS
avatar-seller
VasilyKichigin
BCMAS Exam | Questions & Answers (100 %Score) Latest Updated 2024/2025
Comprehensive Questions A+ Graded Answers | With Expert Solutions

Most commonly used study design: - parallel



Under what conditions can a pharma company provide financial support for conferences and CME? -
The grants/contributions are separate from other company funds



The company has had no control over the selection of content, faculty, or venue



Not required by ADR reporting: - careful selection of clinical trial participants



Required:

-recognition of events

-safety signals are identified against a background of events

-accurate reporting



Individual board members are known as: - advisors



in vitro diagnostic test - example - microbiology culture



in vitro versus in vivo - in vitro describes something "in glass" such as a test tube or petri dish



in vivo is "within a living organism"



Fundamental requirement for ongoing risk evaluations of REMS: - timely data collection



Best practice and ethical standards for reporting research published in medical journals - ICMJE

,T/F: Elements to Assure Safe Use (ETASU) are required medical interventions taken by HCPs prior to
using the drug. - True



Combination product applicant(s) - The company that holds the application for the combination product
as a whole



T/F: Severe birth defects is not an FDA mandated REMS. - False



Export challenge of a medical device company: - Violation of intellectual property rights



Purposes of IIS - develop and support new indication

enhance pt benefits/health outcomes

improve available product safety and



NOT a purpose = support pt community



Goals of pharmacogenomics - Individualize therapies based on genetic differences

Predict individual responses to a drug to decrease adverse drug reactions

Improve the overall efficacy and safety of drugs



NOT a goal = decrease medication adherence



FDA clearance for medical devices - May be given for devices with substantial equivalence to a known
predicate device



Allows the device to be marketed and sold once a Pre-Market Notification has been submitted



May be issued if the device existed in the market prior to 1976



EBM databases - DynaMed

,Cochrane Library



T/F: Presentation skills are not essential for maintaining a position with MA. - False



What would cause the FDA to require post-marketing studies or clinical trials at the time of approval or
afterwards for a new product? - If the FDA becomes aware of new safety information from SADR
reporting.



When first working on a publication, what should authors do to identify their rights, roles, and
responsibilities? - Document the agreement



The process of internal cooperation, coordination, and common standards across the global
pharmaceutical industry is referred to as: - Harmonization



5-step process to respond to a medical information question - 1) Determine who the audience is

2) Understand what the primary question is

3) Develop an appropriate research strategy

4) Choose the best source

5) Assess the information source and answer the question



T/f: SRDs are prepared only for HCPs in response to questions about product(s). - False



Who is required to submit a periodic safety update report? - Marketing authorization holders (MAHs)
according to the data points outlined in the EURD list.



T/F: Surveys are classified as cross-sectional studies. - True



Medical Device User Fees Amendment of 2012 - Allows the FDA to collect user fees for pre-market
approvals to improve the overall review process



T/F: An abbreviated new drug application (ANDA) is submitted to the FDA for generic drugs. - True

, The risk associated with this type of drug may not be well understood. - New drug substance



Amber is an MSL and receives a question from a physician about a medication indication that is not FDA
approved. Which of the following is true? - This is an unsolicited request.

This information is off-label.



A Pharma company is looking to begin the development of a new drug. Why would the company consult
an advisory board? - To provide their opinion on the research and development of the drug



T/F: Under the second-tier regulations, in 21 CFR Part 56 (Institutional Review Board (IRB)) subpart B,
there needs to be a minimum of 2 members in the IRB. - False



Which are considered key items the FDA will contemplate when deciding on whether REMS is needed? -
Seriousness of the disease

Seriousness of side effects

Benefit of the drug



In research which of the terms below describes a distortion caused by other variables to both exposure
and outcome? - confounding



T/F: Medical writers should avoid addressing the public's questions to prevent the spread of health
misinformation. - False



What are some of the ways that companies can benefit from non-mandated Post-Marketing studies? -
Detect any cost-benefits associated with the drugs



Compare a drug with other currently available medications in the same class



Detect other uses of the drugs

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller VasilyKichigin. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $13.48. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

72841 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$13.48
  • (0)
  Add to cart